Search - tctmd.com

Displaying 921 - 940 of 1394

Sort: Relevancy | Date

News Conference News AHA 2017

Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation

Yael L. Maxwell

November 27, 2017

News Daily News

Radial Access Best for PCI Following Thrombolysis in STEMI

Michael O'Riordan

November 27, 2017

News Daily News

Routine Coronary CTA to Rule Out ACS in Acute Chest Pain Questioned in ROMICAT-II Subanalysis

L.A. McKeown

November 21, 2017

News Conference News AHA 2017

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Michael O'Riordan

November 15, 2017

News Conference News AHA 2017

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

Caitlin E. Cox

November 14, 2017

News Conference News AHA 2017

Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation

Michael O'Riordan

November 13, 2017

News Conference News AHA 2017

Low High-Sensitivity Troponin I Cutoff May Allow Discharge From ED for Many

Todd Neale

November 11, 2017

News Conference News AHA 2017

AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More

Shelley Wood

November 09, 2017

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

News Conference News TCT 2017

Shortened DAPT Durations Appear Safe for Patients With ACS Implanted With DES

Todd Neale

November 01, 2017

News Conference News TCT 2017

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Michael O'Riordan

November 01, 2017

Presentation TCT 2017

Debate: EXCEL and NOBLE Prove That PCI Is Still Far From Being an Acceptable Alternative to CABG for Left Main Revascularization, With the Exception of a Small Proportion of Patients!

Presenter: Evald H. Christiansen, Erick Schampaert, John D. Puskas

October 31, 2017

Presentation TCT 2017

Debate: Based on EXCEL and NOBLE, PCI Should Become Class IA for Left Main Revascularization If Technically Feasible, at Least in Intermediate and Low SYNTAX Score Patients!

Presenter: Evald H. Christiansen, Erick Schampaert, Marco V. Wainstein

October 31, 2017

Presentation TCT 2017

Improving Outcomes in Cardiogenic Shock: Issues the Guidelines Dont Discuss

Presenter: Michael Mooney, Holger Thiele, Venu Menon

October 31, 2017

Presentation TCT 2017

Should Recommendations for Left Main PCI Be Revised? Personal Perspectives and the Guidelines Process

Presenter: Antonio Colombo, David E. Kandzari, Stephan Windecker

October 31, 2017

News Conference News TCT 2017

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Todd Neale

October 30, 2017

Presentation TCT 2017

Case Resolution: A High-Risk Patient With Complex Mutlivessel Disease How We Treated

Presenter: Issam D. Moussa, Emmanouil S. Brilakis

October 30, 2017

Presentation TCT 2017

PCI vs CABG in Multivessel Disease: What Do the US Guidelines and AUC Say?

Presenter: Issam D. Moussa, Manesh R. Patel

October 30, 2017

Presentation TCT 2017

PCI vs CABG in Multivessel Disease: What Do the Data and EU Guidelines Say?

Presenter: Issam D. Moussa, Alfredo R. Galassi

October 30, 2017

Presentation TCT 2017

Case Presentation: A High-Risk Patient With Complex Multivessel Disease PCI vs CABG?

Presenter: Issam D. Moussa, Emmanouil S. Brilakis

October 30, 2017

Advertisement

Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation

Radial Access Best for PCI Following Thrombolysis in STEMI

Routine Coronary CTA to Rule Out ACS in Acute Chest Pain Questioned in ROMICAT-II Subanalysis

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation

Low High-Sensitivity Troponin I Cutoff May Allow Discharge From ED for Many

AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Shortened DAPT Durations Appear Safe for Patients With ACS Implanted With DES

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Debate: EXCEL and NOBLE Prove That PCI Is Still Far From Being an Acceptable Alternative to CABG for Left Main Revascularization, With the Exception of a Small Proportion of Patients!

Debate: Based on EXCEL and NOBLE, PCI Should Become Class IA for Left Main Revascularization If Technically Feasible, at Least in Intermediate and Low SYNTAX Score Patients!

Improving Outcomes in Cardiogenic Shock: Issues the Guidelines Dont Discuss

Should Recommendations for Left Main PCI Be Revised? Personal Perspectives and the Guidelines Process

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Case Resolution: A High-Risk Patient With Complex Mutlivessel Disease How We Treated

PCI vs CABG in Multivessel Disease: What Do the US Guidelines and AUC Say?

PCI vs CABG in Multivessel Disease: What Do the Data and EU Guidelines Say?

Case Presentation: A High-Risk Patient With Complex Multivessel Disease PCI vs CABG?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content